Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma
Understanding the Pathway article: http://ascopubs.org/doi/full/10.1200/jco.2015.64.9970
The Journal of Clinical Oncology's "Understanding the Pathway" articles accompany an Original Report and describe the underlying pathway or biological process, explain its relevance to the original report, and highlight future therapeutic or investigational directions pertaining to the pathway in cancer.
Видео Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma канала ASCOcancer
The Journal of Clinical Oncology's "Understanding the Pathway" articles accompany an Original Report and describe the underlying pathway or biological process, explain its relevance to the original report, and highlight future therapeutic or investigational directions pertaining to the pathway in cancer.
Видео Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma канала ASCOcancer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
2022 ASCO GI Cancers Symposium Keynote: Impact of the COVID-19 Pandemic on Equity and Access to CareInternational Membership InformationGastrointestinal Cancers in Older AdultsWellness AdviceASCO COVID 19 and Cancer PresscastHow is CancerLinQ helping to expand access to clinical trials?Deep Learning Based Predictor of Future Lung Cancer RiskTriplet Therapy for Metastatic Hormone-sensitive Prostate CancerDr. Angela DeMichele on Why You Should Attend Our Flagship Best of ASCO MeetingAre All Chimeric Antigen Receptors Created Equal?I Live to Conquer Cancer - Dr. DizonDetecting and Managing T-DXd–Related Interstitial Lung Disease: The Five “S” RulesRegister Now: 2022 ASCO Annual MeetingACReC Session 5 -- Improving Palliative Care Through Research -- July 9, 2021I Live to Conquer Cancer - Oncologist Group and Patient AdvocateAn Updated Analysis of the Combined TEXT and SOFT Trials: A 13-year Follow-UpDr. Eric Winer Invites You to Attend #ASCO23Dr. Vokes Discusses 2022 ASCO Annual MeetingQOPI Overview - August 2018 (Spanish disclaimer)Cancer Survivorship in Older AdultsASCO's First-Ever Clinical Trial: The TAPUR Study